Gate Bioscience Emerges from Stealth and Introduces Molecular Gates, a New Class of Small Molecule Therapeutics

Company Backed by $60M Series A Financing from Versant Ventures, a16z Bio + Health, ARCH Venture Partners, and GV BRISBANE, Calif., Nov. 1, 2023 /PRNewswire/ — Gate Bioscience, a biotechnology company creating a new class of medicines called Molecular Gates, today unveiled the company…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks